FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

28006711000001106: Matoride XL 18mg tablets (Sandoz Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Dec 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
88518101000001119 Matoride XL 18mg tablets (Sandoz Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
88518201000001114 Matoride XL 18mg tablets (Sandoz Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Matoride XL 18mg tablets (Sandoz Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Matoride XL 18mg tablets (Sandoz Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Matoride XL 18mg tablets (Sandoz Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Matoride XL 18mg tablets (Sandoz Ltd) 30 tablet Is a Methylphenidate 18mg modified-release tablets 30 tablet true Inferred relationship Existential restriction modifier
Matoride XL 18mg tablets (Sandoz Ltd) 30 tablet Has AMP Matoride XL 18mg tablets (Sandoz Ltd) true Inferred relationship Existential restriction modifier
Matoride XL 18mg tablets (Sandoz Ltd) 30 tablet Has excipient Butylated hydroxytoluene false Inferred relationship Existential restriction modifier
Matoride XL 18mg tablets (Sandoz Ltd) 30 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Matoride XL 18mg tablets (Sandoz Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Matoride XL 18mg tablets (Sandoz Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Matoride XL 18mg tablets (Sandoz Ltd) 30 tablet Has specific active ingredient Methylphenidate hydrochloride true Inferred relationship Existential restriction modifier
Matoride XL 18mg tablets (Sandoz Ltd) 30 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Matoride XL 18mg tablets (Sandoz Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Matoride XL 18mg tablets (Sandoz Ltd) 30 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Matoride XL 18mg tablets (Sandoz Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Matoride XL 18mg tablets (Sandoz Ltd) 30 tablet VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
Matoride XL 18mg tablets (Sandoz Ltd) 30 tablet VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start